BLFS logo
BLFS NASDAQ US

BioLife Solutions, Inc. - Common Stock

Healthcare · Life Sciences Tools & Services Sito web · IPO Nov 1989
$19,51
▲ +$0,22 (+1,14%)
Vol. 209K
5
Punteggio di Qualità
fail
Cap. mercato
$1.2B
ROE
-0,9%
Margine
-20,2%
D/E
2,12
Beta
1,93
52W
$19–$30

Consenso Wall Street

16 analisti · Apr 2026
4
Acquisto forte
11
Compra
1
Mantieni
0
Vendi
0
Vendita forte
93,8%
Rating Compra

Grafico dei Prezzi

Titoli simili

SHC
Sotera Health Co
P/E 90,4
$5.0B
TXG
10X Genomics Inc
$2.1B
ADPT
Adaptive Biotechnologies Corp
$2.5B
AZTA
Azenta Inc
$1.5B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7,1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M

Utili

Tasso di battuta: 100,0%
Prossimo report Mag 06, 2026
Stima EPS: $0,02
Trimestre EPS Stimato EPS Effettivo Sorpresa
Mar 2026 $0,02 — —
Dic 2025 $-0,02 $0,22 +$0,24
Set 2025 $-0,01 $0,01 +$0,02
Giu 2025 $-0,04 $-0,01 +$0,03

Ricavi e utili trimestrali

Trimestre 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Ricavi — -$3.4M $23.9M $25.4M $28.1M $18.8M
Utile netto — $12.5M -$448K -$15.8M $621K $11.1M

Trend fondamentali

Metrica 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -1.6% -1.6% -1.6% -1.6% -0.9% -0.9%
P/E (TTM) — — — — — —
Net Margin -62.3% -22.5% -22.5% -22.5% -20.2% -20.2%
Gross Margin 64.6% 60.7% 60.7% 60.7% 64.8% 64.8%
D/E Ratio 2.90 2.90 2.90 2.90 2.12 2.12
Current Ratio 4.43 4.43 4.43 4.43 4.66 4.66

Rapporti chiave

ROA (TTM)
-0,8%
P/S (TTM)
15,73
P/B
3,4
EPS (TTM)
$-0,06
CF/Share
$-2,09
Crescita ricavi 3A
-11,6%
52W High
$29,62
52W Low
$19,10
$19,10 Intervallo 52 settimane $29,62

Salute finanziaria

Flusso di cassa libero
-$9.6M
Debito netto
-$15.1M
Liquidità
$33.0M
Debito totale
$17.9M
Aggiornato al Dic 31, 2025

Як BLFS виглядає на тлі конкурентів у Life Sciences Tools & Services?

Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній

BLFS ABCL ADPT AZTA BRKR

Оцінка BLFS vs аналоги Life Sciences Tools & Services

P/E
—
▼ 0% sotto peer (32,5)
vs Peer
vs Settore
Valore equo
P/S
15,7
▲ 312% sopra peer (3,8)
vs Peer
vs Settore
Sopravvalutato
P/B
3,4
▼ 8% sotto peer (3,7)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
—
▼ 0% sotto peer (0,5%)
vs Peer
vs Settore
Rendimento basso

Прибутковість BLFS vs аналоги Life Sciences Tools & Services

ROE
-0,9%
▲ 72% sopra peer (-3,3%)
vs Peer
vs Settore
Sotto media
Net margin
-20,2%
▼ 115% sotto peer (-9,4%)
vs Peer
vs Settore
Debole
Валова маржа
64,8%
▲ 35% sopra peer (48,0%)
vs Peer
vs Settore
Top livello
ROA
-0,8%
▲ 69% sopra peer (-2,6%)
vs Peer
vs Settore
Sotto media

Фінансове здоровʼя BLFS vs аналоги Life Sciences Tools & Services

D/E ratio
2,1
▼ 94% sotto peer (36,5)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
4,7
▲ 38% sopra peer (3,4)
vs Peer
vs Settore
Liquidità forte
Beta
1,9
▲ 36% sopra peer (1,4)
vs Peer
vs Settore
Più volatile

Радар фундаменталів BLFS

BLFS Mediana peer Industria

BLFS прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

BLFS vs аналоги: ключові метрики

Attività insider

Neutral
Acquisti
0
Vendite
0
FOSTER KAREN A
Chief Operating Officer · Mar 09
97423 shs
BERARD TODD C.J.
Officer · Mar 03
353 shs
MATHEW ABY J
Officer · Mar 03
529 shs
WICHTERMAN TROY
Chief Financial Officer · Mar 03
588 shs
WERNER SEAN
Chief Technology Officer · Mar 03
111 shs
FOSTER KAREN A
Officer · Mar 03
418 shs
AEBERSOLD SARAH
Officer · Mar 03
219 shs
WICHTERMAN TROY
Chief Financial Officer · Feb 24
96016 shs
WERNER SEAN
Chief Technology Officer · Feb 24
24116 shs
DE GREEF RODERICK
Chief Executive Officer · Feb 24
508045 shs
Ultimo 90 giorni

Principali azionisti

Top 5: 49,83%
Casdin Capital, LLC
12,33%
$110.7M
Blackrock Inc.
12,24%
$109.9M
T. Rowe Price Investment Ma…
10,73%
$96.3M
Invesco Ltd.
8,14%
$73.1M
Vanguard Group Inc
6,39%
$57.4M
Aggiornato al Dic 31, 2025

Ultime notizie

Nessuna notizia correlata ancora